Tin Mao
Molecular and Cell Biology
Benitec Biopharma
Australia
Biography
Tin Mao is a Senior Scientist with a background in molecular and cellular immunology. He joined Benitec Biopharma in May 2014 and is currently the lead scientist overseeing the company’s research efforts for the Hepatitis B program. His postdoctoral training at Stanford University studying the role of microRNAs in immune cell development sparked a longstanding interest in translating a powerful biological process of RNA interference into life-saving therapeutics. Excited about the prospects of RNAi therapeutics following his postdoctoral experience, Tin joined Tacere Therapeutics in 2008 as a Research Scientist and was a significant contributor on their Hepatitis C and Age-Related Macular Degeneration programs. Tin has leveraged his expertise in microRNA biology to design and improve upon first generation shRNA expression molecules. This technology became the basis by which therapeutic shRNAs were designed for other in-house programs. Tin holds a B.S. in Biochemistry and a Ph.D. in Immunology, both from the University of California at Davis.
Research Interest
Molecular and Cell Biology
